Akumin Inc. provides outpatient diagnostic imaging services in the United States. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The company provides various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures; and online medical bill payment services. As of December 31, 2020, the company operated 127 outpatient diagnostic imaging centers located in Florida, Texas, Pennsylvania, Delaware, Georgia, Illinois, and Kansas. Akumin Inc. is headquartered in Plantation, Florida.
IPO Year:
Exchange: NASDAQ
Website: akumin.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/14/2022 | $3.50 → $3.00 | Buy → Speculative Buy | Canaccord Genuity |
Canaccord Genuity downgraded Akumin from Buy to Speculative Buy and set a new price target of $3.00 from $3.50 previously
EFFECT - AKUMIN INC. (0001776197) (Filer)
15-12G - AKUMIN INC. (0001776197) (Filer)
S-8 POS - AKUMIN INC. (0001776197) (Filer)
POS AM - AKUMIN INC. (0001776197) (Filer)
8-K - AKUMIN INC. (0001776197) (Filer)
8-K - AKUMIN INC. (0001776197) (Filer)
10-Q - AKUMIN INC. (0001776197) (Filer)
8-K - AKUMIN INC. (0001776197) (Filer)
8-K - AKUMIN INC. (0001776197) (Filer)
25-NSE - AKUMIN INC. (0001776197) (Subject)
Krishna Kumar, Current President & Chief Operating Officer, Appointed Chief Executive Officer Chandra Westergaard Named General Counsel PLANTATION, Fla., Feb. 8, 2024 /CNW/ - Akumin Inc. ("Akumin" or the "Company") announced today that Krishna Kumar, who has served as President and Chief Operating Officer at the Company, has been appointed Chief Executive Officer, effective immediately. He succeeds Riadh Zine, Akumin's Founder, who is stepping down as Chairman and Chief Executive Officer. Akumin also announced that Chandra Westergaard has been named General Counsel and will oversee the Company's legal and compliance functions. "On behalf of Akumin, I would like to thank Riadh for his dedica
Akumin well-positioned to continue providing top-quality radiology and oncology services to patients, health systems, hospitals, and physician groups across the U.S. PLANTATION, Fla., Feb. 6, 2024 /CNW/ - Akumin Inc. ("Akumin" or the "Company") today announced that it has completed its deleveraging transaction, becoming a private company wholly-owned by Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets. The deleveraging and recapitalization transaction was implemented through a voluntary, court-supervised financial restructuring process, which is now complete. "We are pleased to have concluded this process and are excited to enter our next chapt
/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/ PLANTATION, Fla., Jan. 31, 2024 /CNW/ - Akumin Inc. (together with its subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:AKU) (OTC Pink Open Market: AKUMQ) announced today that its previously announced restructuring transaction involving Stonepeak as well as its bondholders, lenders, shareholders and other stakeholders under a prepackaged chapter 11 plan of reorganization (the "Prepackaged Plan") is expected to become effective on or around February 6, 2024 (the "Effective Date"), subject to satisfaction of all of the remaining conditions to the closing of the restructuring transaction. On
PLANTATION, Fla., Dec. 29, 2023 /CNW/ - Akumin Inc. (together with its subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:AKU) (OTC Pink Open Market: AKUMQ) announced today that its Board of Directors has appointed Ronald J. Bienias, Akumin's Chief Restructuring Officer and Partner and Managing Director of AlixPartners, LLP, as Interim Chief Financial Officer, effective today. He will also maintain his current role as Chief Restructuring Officer. Ronald's appointment follows the resignation of David Kretschmer, as Akumin's Chief Financial Officer effective today. Ronald has more than 20 years of experience serving in interim leadership roles or as an advisor at both large and
PLANTATION, Fla., Dec. 12, 2023 /CNW/ - Akumin Inc. (together with its subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:AKU) (OTC:AKUMQ) announced today its financial results for the quarter ended September 30, 2023 by filing its Periodic Report on Form 10-Q for the quarterly period ended September 30, 2023 (the "Form 10-Q") with the U.S. Securities and Exchange Commission on the Electronic Data Gathering, Analysis, and Retrieval system ("EDGAR") and with the Canadian Securities Administrators on the System for Electronic Document Analysis and Retrieval Plus ("SEDAR+"). The Form 10-Q is available to be viewed by interested parties under the Company's profile on EDGAR at www.s
PLANTATION, Fla., Aug. 9, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) announced today that it has changed its auditor from Ernst & Young LLP ("EY") to Deloitte & Touche LLP ("Deloitte"). Effective as of August 9, 2023, the audit committee (the "Audit Committee") of the board of directors (the "Board") of the Company dismissed EY as the Company's independent registered public accounting firm. EY audited the Company's financial statements for each of the past two fiscal years ended December 31, 2022 and 2021, and EY's reports did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or
PLANTATION, Fla., Aug. 9, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended June 30, 2023. Second Quarter 2023 Highlights Akumin delivered second quarter same-store volume performance on a consolidated basis as follows:+3.1% for MRI+16.5% for PET/CT+3.4% for Oncology Patient StartsThe Company reported revenue totaling $184.8 million for the second quarter, a $7.3 million or 4% decrease over the second quarter of last year.
PLANTATION, Fla., Aug. 8, 2023 /PRNewswire/ - Akumin Inc. (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, Thursday, August 10, 2023, to discuss its second quarter 2023 financial results. The financial results are expected to be available on Wednesday, August 9, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q2-2023-Results-Dial-In-Numbers or via webcast at https://akum.in/Q2-2023-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call
PLANTATION, Fla., June 12, 2023 /CNW/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023. Krishna has valuable experience and exceptional insight into the radiology space, having served as Senior Vice President & Business Leader - Precision Diagnosis at Philips North America, where he built a top performing team and business, over the last four years. Prior to this role, he led global businesses in Pathology, Oncology and Neuro at Philips based in Amsterdam, Netherlands from 2015-2019 and prior thereto was the CEO of Philips India. Before joini
PLANTATION, Fla., June 12, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023. Krishna has valuable experience and exceptional insight into the radiology space, having served as Senior Vice President & Business Leader - Precision Diagnosis at Philips North America, where he built a top performing team and business, over the last four years. Prior to this role, he led global businesses in Pathology, Oncology and Neuro at Philips based in Amsterdam, Netherlands from 2015-2019 and prior thereto was the CEO of Philips India. Befor
PLANTATION, Fla., Dec. 29, 2023 /CNW/ - Akumin Inc. (together with its subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:AKU) (OTC Pink Open Market: AKUMQ) announced today that its Board of Directors has appointed Ronald J. Bienias, Akumin's Chief Restructuring Officer and Partner and Managing Director of AlixPartners, LLP, as Interim Chief Financial Officer, effective today. He will also maintain his current role as Chief Restructuring Officer. Ronald's appointment follows the resignation of David Kretschmer, as Akumin's Chief Financial Officer effective today. Ronald has more than 20 years of experience serving in interim leadership roles or as an advisor at both large and
PLANTATION, Fla., Aug. 9, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) announced today that it has changed its auditor from Ernst & Young LLP ("EY") to Deloitte & Touche LLP ("Deloitte"). Effective as of August 9, 2023, the audit committee (the "Audit Committee") of the board of directors (the "Board") of the Company dismissed EY as the Company's independent registered public accounting firm. EY audited the Company's financial statements for each of the past two fiscal years ended December 31, 2022 and 2021, and EY's reports did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or
PLANTATION, Fla., June 12, 2023 /CNW/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023. Krishna has valuable experience and exceptional insight into the radiology space, having served as Senior Vice President & Business Leader - Precision Diagnosis at Philips North America, where he built a top performing team and business, over the last four years. Prior to this role, he led global businesses in Pathology, Oncology and Neuro at Philips based in Amsterdam, Netherlands from 2015-2019 and prior thereto was the CEO of Philips India. Before joini
PLANTATION, Fla., June 12, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023. Krishna has valuable experience and exceptional insight into the radiology space, having served as Senior Vice President & Business Leader - Precision Diagnosis at Philips North America, where he built a top performing team and business, over the last four years. Prior to this role, he led global businesses in Pathology, Oncology and Neuro at Philips based in Amsterdam, Netherlands from 2015-2019 and prior thereto was the CEO of Philips India. Befor
SANTA CLARA, Calif., May 9, 2023 /PRNewswire/ -- Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced that the Glassbeam Board of Directors has appointed Rhonda Longmore-Grund as Chairman of the Board, effective May 1, 2023. Rhonda is shifting to the Chairman role as Eric Milledge transitions to a Board Director position. "I feel very privileged to take on this role at Glassbeam given the challenges that the healthcare industry faces globally. Glassbeam is providing innovative solutions that enable health systems, provide
SANTA CLARA, Calif., Dec. 1, 2022 /PRNewswire/ -- Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced that Rhonda Longmore-Grund will be joining the Board of Directors of Glassbeam. Ms. Longmore-Grund is the former President & CEO of Alliance Healthcare Services, a leading provider of comprehensive radiology and oncology services, partnering with over 1,000 hospitals across 46 states in the US to provide high quality, compassionate care to ~1 million patients each year. When Alliance was acquired in 2021 by Akumin Inc. (NASDAQ:AKU), Ms. Longmore-Grund served as President, Co-CEO and a Director of the newly merged Akumin/Alliance company
PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr
PLANTATION, Fla., June 30, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) (the "Company") held its annual general and special meeting of shareholders (the "Meeting") today, June 30, 2022, on a virtual meeting platform. A total 52,829,002 shares, representing approximately 59.0% of shares outstanding, were represented at the Meeting or by proxy at the Meeting. Further to TSX reporting requirements, the voting in relation to the election of directors was conducted at the Meeting and the results were as follows: Nominee Vote For# (%) Votes Withheld# (%) Not Voted # Thomas Davies 50,795,166 (99.93) 35,197 (0.07) 1,998,639 Stanley Dunford 50,795,366 (99.93) 34,997 (0.07) 1,998,639 Haichen
PLANTATION, Fla, May 13, 2021 /CNW/ - Akumin Inc. ("Akumin" or the "Corporation") (NASDAQ:AKU) (TSX:AKU) held its annual general and special meeting of shareholders (the "Meeting") today, May 13, 2021, on a virtual meeting platform. A total 47,315,152 shares, representing approximately 67.421% of shares outstanding, were represented at the meeting or by proxy at the meeting. Further to TSX reporting requirements, the voting in relation to the election of directors was conducted at the Meeting and the results were as follows: Nominee Votes For Votes Withheld Not Voted # (%) # (%) # Thomas Davies 45,687,401 (98.535%) 679,492 (1.465%) 948,259 Stan Dunford 46,365,418 (99.997%) 1,475 (0.003%) 948
3 - AKUMIN INC. (0001776197) (Issuer)
3 - AKUMIN INC. (0001776197) (Issuer)
4 - AKUMIN INC. (0001776197) (Issuer)
3 - AKUMIN INC. (0001776197) (Issuer)
3 - AKUMIN INC. (0001776197) (Issuer)
4 - AKUMIN INC. (0001776197) (Issuer)
4 - AKUMIN INC. (0001776197) (Issuer)
4 - AKUMIN INC. (0001776197) (Issuer)
4 - AKUMIN INC. (0001776197) (Issuer)
4 - AKUMIN INC. (0001776197) (Issuer)
SC 13G/A - AKUMIN INC. (0001776197) (Subject)
SC 13G - AKUMIN INC. (0001776197) (Subject)
SC 13G/A - AKUMIN INC. (0001776197) (Subject)
SC 13G/A - AKUMIN INC. (0001776197) (Subject)
SC 13D/A - AKUMIN INC. (0001776197) (Subject)
SC 13D - AKUMIN INC. (0001776197) (Subject)
SC 13D/A - AKUMIN INC. (0001776197) (Subject)
SC 13G/A - AKUMIN INC. (0001776197) (Subject)
SC 13G/A - AKUMIN INC. (0001776197) (Subject)
SC 13G/A - AKUMIN INC. (0001776197) (Subject)
/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/ PLANTATION, Fla., Jan. 31, 2024 /CNW/ - Akumin Inc. (together with its subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:AKU) (OTC Pink Open Market: AKUMQ) announced today that its previously announced restructuring transaction involving Stonepeak as well as its bondholders, lenders, shareholders and other stakeholders under a prepackaged chapter 11 plan of reorganization (the "Prepackaged Plan") is expected to become effective on or around February 6, 2024 (the "Effective Date"), subject to satisfaction of all of the remaining conditions to the closing of the restructuring transaction. On
PLANTATION, Fla., Aug. 9, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended June 30, 2023. Second Quarter 2023 Highlights Akumin delivered second quarter same-store volume performance on a consolidated basis as follows:+3.1% for MRI+16.5% for PET/CT+3.4% for Oncology Patient StartsThe Company reported revenue totaling $184.8 million for the second quarter, a $7.3 million or 4% decrease over the second quarter of last year.
PLANTATION, Fla., Aug. 8, 2023 /PRNewswire/ - Akumin Inc. (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, Thursday, August 10, 2023, to discuss its second quarter 2023 financial results. The financial results are expected to be available on Wednesday, August 9, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q2-2023-Results-Dial-In-Numbers or via webcast at https://akum.in/Q2-2023-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call
PLANTATION, Fla., May 10, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended March 31, 2023. First Quarter 2023 Highlights Akumin delivered first quarter same-store volume performance on a consolidated basis as follows:+4.0% for MRI+16.1% for PET/CT+7.6% for Oncology Patient StartsThe Company reported revenue totaling $187.6 million for the first quarter, a $1.3 million or 1% increase over the first quarter of last year.Net
PLANTATION, Fla., May 4, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, May 11, 2023, to discuss its first quarter 2023 financial results. The financial results are expected to be available on Wednesday, May 10, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q1-2023-Results-Dial-In-Numbers or via webcast at https://akum.in/Q1-2023-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to
PLANTATION, Fla., March 16, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter and year ended December 31, 2022. Fourth Quarter 2022 Highlights Akumin delivered fourth quarter same-store volume performance on a consolidated, pro forma basis as follows:-0.3% for MRI+7.8% for PET/CT+8.0% for Oncology Patient StartsThe Company reported revenue totaling $184.6 million for the fourth quarter, a $5.2 million or 3% increase over the fou
PLANTATION, Fla., March 10, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, March 17, 2023, to discuss its year-end 2022 financial results. The financial results are expected to be available on Thursday, March 16, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/2022-YearEndResults-Audio or via webcast at https://akum.in/2022-YearEndResults-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to
PLANTATION, Fla., Nov. 9, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Highlights Akumin's radiology business delivered third quarter same-store volume performance on a consolidated, pro forma basis assuming the Company's acquisition of Alliance HealthCare Services was completed as of January 1, 2021:+0.2% for MRI+7.8% for PET/CT(2.5%) for Total Radiology Procedures(0.2%) for Onco
PLANTATION, Fla., Nov. 3, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, November 10, 2022, to discuss its third quarter 2022 financial results. The financial results are expected to be available on Wednesday, November 9, 2022. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q3-2022-Results-Audio or via webcast at https://akum.in/Q3-2022-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to
PLANTATION, Fla., Aug. 9, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups with comprehensive solutions addressing outsourced radiology and oncology service line needs, announced today its financial results for the quarter ended June 30, 2022. Second Quarter 2022 Highlights Akumin's radiology business delivered strong quarterly same store volume performance on a consolidated pro forma basis, which assumes the Company's acquisition of Alliance HealthCare Services, Inc. ("Alliance") was completed as of January 1, 2021:+2.0% for MRI+6.4% for PET/CT+4.5% for Total Radiology Pro
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded down 0.19% to 33,062.85 while the NASDAQ rose 0.80% to 13,088.09. The S&P 500 also rose, gaining, 0.28% to 4,236.12. Check This Out: This Analyst With 85% Accuracy Rate Sees More Than 42% Upside In Amazon.com - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts Leading and Lagging Sectors Communication services shares rose by 1.3% on Monday. In trading on Monday, energy shares dipped by 1.9%. Top Headline The Chicago Fed National Activity Index climbed to +0.02 in September versus a revised reading of -0.22 in the prio
Gainers INVO Bioscience, Inc. (NASDAQ:INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction. LumiraDx Limited (NASDAQ:LMDX) shares climbed 187.4% to $0.25 after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub. Akumin Inc. (NASDAQ:AKU) shares climbed 125% to $0.3279 after the company reached an agreement with Stonepeak to become a private company. Textainer Group Holdings Limited (NYSE:TGH) shares gained 44.5% to $49.33 after the company agreed to be acquired by Stonepeak for $7.4 billion. Twin Ridge Capital Acquisition Co
U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday. The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500 also rose, gaining, 0.29% to 4,236.55. Check This Out: This Analyst With 85% Accuracy Rate Sees More Than 42% Upside In Amazon.com - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts Leading and Lagging Sectors Communication services shares rose by 0.9% on Monday. In trading on Monday, energy shares dipped by 1%. Top Headline The Chicago Fed National Activity Index climbed to +0.02 in September versus a revised reading of -0.22 in the prior mont
https://akumin.com/investor-relations/press-releases/akumin-inc-reaches-agreement-with-stonepeak-to-become-a-private-company/Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary course PLANTATION, FLORIDA, October 20, 2023 — Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU, TSX:AKU) announ
U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell 0.33% to 12,940.56. The S&P 500 also fell, dropping, 0.33% to 4,210.14. Check This Out: This Analyst With 85% Accuracy Rate Sees More Than 42% Upside In Amazon.com - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts Leading and Lagging Sectors Health care shares fell by just 0.1% on Monday. In trading on Monday, energy shares dipped by 1.2%. Top Headline The Chicago Fed National Activity Index climbed to +0.02 in September versus a revised reading of
Gainers LumiraDx Limited (NASDAQ:LMDX) shares surged 151.7% to $0.2190 in pre-market trading after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub. Akumin Inc. (NASDAQ:AKU) shares rose 56.6% to $0.2285 in pre-market trading after the company reached an agreement with Stonepeak to become a private company. Next.e.GO N.V. (NASDAQ:EGOX) rose 47.5% to $2.08 in pre-market trading. Next.e.GO Mobile and Athena Consumer Acquisition announced the completion of their previously announced business combination. Textainer Group Holdings Limited (NYSE:TGH) shares gained 42.6% to $48.69
- SEC Filing
Gainers Femasys Inc. (NASDAQ:FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment. Tharimmune Inc (NASDAQ:THAR) shares rose 101.4% to $0.4450 in pre-market trading after falling around 5% on Monday. Infobird Co., Ltd (NASDAQ:IFBD) shares gained 31.1% to $0.1709 in pre-market trading. Infobird recently announced receipt of delinquency notification letter from the Nasdaq. Avalo Therapeutics, Inc. (NASDAQ:AVTX) gained 19.3% to $0.1945 in pre-market trading after jumping over 36% on Monday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares gained 53.3% to $0.23 in pre-market trading. Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) shares surged 37.1% to $1.48 in pre-market trading. Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares rose 26.3% to $4.31 in pre-market trading after gaining over 4% on Friday. Neptune Wellness Solutions Inc. (NASDAQ:NEPT) rose 22.1% to $0.2955 in pre-market trading. Neptune Wellness Solutions shares jumped 75% on Friday after the company reported first-quarter results and entered into a binding term sheet with Morgan Stanley providing the option to exchange the existing debt of Sprout Organics. The Growth for Good Acquisition Corporation (